Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1799-1806
Published online before print October 9, 2006, doi: 10.1161/CIRCULATIONAHA.106.624502
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/17/1799    most recent
CIRCULATIONAHA.106.624502v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Levkau, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Levkau, B.
Related Collections
Right arrow Myocardial cardiomyopathy disease

(Circulation. 2006;114:1799-1806.)
© 2006 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice

Paulus Kirchhof, MD; Larissa Fabritz, MD; Melanie Zwiener, VetD; Henning Witt, PhD; Michael Schäfers, MD; Stephan Zellerhoff, MD; Matthias Paul, MD; Timur Athai, BS; Karl-Heinz Hiller, PhD; Hideo A. Baba, MD; Günter Breithardt, MD; Patricia Ruiz, PhD; Thomas Wichter, MD; Bodo Levkau, MD

From the Department of Cardiology and Angiology (P.K., L.F., M.Z., S.Z., M.P., T.A., G.B., T.W.) and Department of Nuclear Medicine (M.S.), Hospital of the University of Muenster, Muenster, Germany; Interdisciplinary Center for Clinical Research (P.K., L.F., M.Z., H.W., M.S., T.W.), University of Muenster, Muenster, Germany; Center for Cardiovascular Research (H.W., P.R.), Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Experimental Physics (K.-H.H.), University of Wuerzburg, Wuerzburg, Germany; and Department of Pathology (H.A.B.) and Institute of Pathophysiology (B.L.), Hospital of the University of Duisburg-Essen, Duisburg-Essen, Germany.

Correspondence to Paulus Kirchhof, MD, Department of Cardiology and Angiology, Hospital of the University of Muenster, Albert-Schweitzer-Straße 33, D-48149 Münster, Germany. E-mail kirchhp{at}uni-muenster.de

Received March 12, 2006; revision received July 17, 2006; accepted July 21, 2006.

Background— Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disorder that causes sudden death and right ventricular heart failure in the young. Clinical data suggest that competitive sports may provoke ARVC in susceptible persons. Genetically, loss-of-function mutations in desmosomal proteins (plakophilin, desmoplakin, or plakoglobin) have been associated with ARVC. To test the hypothesis that reduced desmosomal protein expression causes ARVC, we studied the cardiac effects of heterozygous plakoglobin deficiency in mice.

Methods and Results— Ten-month-old heterozygous plakoglobin-deficient mice (plakoglobin+/–) had increased right ventricular volume, reduced right ventricular function, and spontaneous ventricular ectopy (all P<0.05). Left ventricular size and function were not altered. Isolated, perfused plakoglobin+/– hearts had spontaneous ventricular tachycardia of right ventricular origin and prolonged right ventricular conduction times compared with wild-type hearts. Endurance training accelerated the development of right ventricular dysfunction and arrhythmias in plakoglobin+/– mice. Histology and electron microscopy did not identify right ventricular abnormalities in affected animals.

Conclusions— Heterozygous plakoglobin deficiency provokes ARVC. Manifestation of the phenotype is accelerated by endurance training. This suggests a functional role for plakoglobin and training in the development of ARVC.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
DMMHome page
M. D. McCauley and X. H. T. Wehrens
Animal models of arrhythmogenic cardiomyopathy
Dis. Model. Mech., November 1, 2009; 2(11-12): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Pilichou, C. A. Remme, C. Basso, M. E. Campian, S. Rizzo, P. Barnett, B. P. Scicluna, B. Bauce, M. J.B. van den Hoff, J. M.T. de Bakker, et al.
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
J. Exp. Med., August 3, 2009; 206(8): 1787 - 1802.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al.
Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study.
J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
A. La Gerche, A. J. Taylor, and D. L. Prior
Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions.
J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 350 - 363.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. J.D. Boukens, V. M. Christoffels, R. Coronel, and A. F.M. Moorman
Developmental Basis for Electrophysiological Heterogeneity in the Ventricular and Outflow Tract Myocardium As a Substrate for Life-Threatening Ventricular Arrhythmias
Circ. Res., January 2, 2009; 104(1): 19 - 31.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna
Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al.
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Marcus and J. A. Towbin
The Mystery of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: From Observation to Mechanistic Explanation
Circulation, October 24, 2006; 114(17): 1794 - 1795.
[Full Text] [PDF]